COLBY DOEPEL: Open Payments
NPI 1306013578 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 68 payments from 10 companies in 2025. Trend: 2023 $5,095 · 2024 $5,549 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 51 | $764 |
| Amgen Inc. | 3 | $204 |
| TG Therapeutics, Inc. | 4 | $121 |
| GENZYME CORPORATION | 2 | $72 |
| ABBVIE INC. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Celgene Corporation | 1 | $33 |
| Genentech USA, Inc. | 1 | $24 |
| Genentech, Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $16 |
Products named: UPLIZNA, BRIUMVI, QULIPTA, KESIMPTA, ZEPOSIA, Ocrevus Zunovo, Ocrevus, TYSABRI.
Industry payments across GA — which companies pay providers there.
